The development and characterization of a CRISPR/Cas9-mediated PD-1 functional knockout rat as a tool to study idiosyncratic drug reactions
- 16 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 198 (2) , 233-245
Abstract
Idiosyncratic drug reactions are rare but serious adverse drug reactions unrelated to the known therapeutic properties of the drug and manifest in only a small percentage of the treated population. Animal models play an important role in advancing mechanistic studies examining idiosyncratic drug reactions. However, to be useful, they must possess similarities to those seen clinically. Although mice currently represent the dominant mammalian genetic model, rats are advantageous in many areas of pharmacologic study where their physiology can be examined in greater detail and is more akin to that seen in humans. In the area of immunology, this includes autoimmune responses and susceptibility to diabetes, in which rats more accurately mimic disease states in humans compared with mice. For example, oral nevirapine treatment can induce an immune-mediated skin rash in humans and rats, but not in mice due to the absence of the sulfotransferase required to form reactive metabolites of nevirapine within the skin. Using CRISPR-mediated gene editing, we developed a modified line of transgenic rats in which a segment of IgG-like ectodomain containing the core PD-1 interaction motif containing the native ligand and therapeutic antibody domain in exon 2 was deleted. Removal of this region critical for mediating PD-1/PD-L1 interactions resulted in animals with an increased immune response resulting in liver injury when treated with amodiaquine.Keywords
Funding Information
- Canadian Institutes of Health Research
- Pfizer Canada
- Ontario Graduate Scholarship
- Glaxo Wellcome-Drug Sunnybrook Drug Safety Clinic Graduate Student Fellowship
This publication has 48 references indexed in Scilit:
- Engineering Point Mutant and Epitope‐Tagged Alleles in Mice Using Cas9 RNA‐Guided NucleaseCurrent Protocols in Mouse Biology, 2018
- Children’s Health Must Remain a Focus in the Recovery From Hurricane HarveyJAMA Pediatrics, 2017
- Inhibition of immune tolerance unmasks drug‐induced allergic hepatitisHepatology, 2015
- Treatment of PD‐1−/− mice with amodiaquine and anti‐CTLA4 leads to liver injury similar to idiosyncratic liver injury in patientsHepatology, 2014
- Development and Applications of CRISPR-Cas9 for Genome EngineeringCell, 2014
- Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunityAutoimmunity Reviews, 2013
- Gene Targeting in Mice: A Review2013
- Animal Models of Idiosyncratic Drug Reactions2012
- Models of Nociception: Hot‐Plate, Tail‐Flick, and Formalin Tests in RodentsCurrent Protocols in Neuroscience, 2007
- Advances in transgenic rat productionTransgenic Research, 2006